Matches in Wikidata for { <http://www.wikidata.org/entity/Q93368876> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q93368876 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q93368876 description "scientific article published on 01 May 2019" @default.
- Q93368876 description "wetenschappelijk artikel" @default.
- Q93368876 description "наукова стаття, опублікована 1 травня 2019" @default.
- Q93368876 name "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 name "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 type Item @default.
- Q93368876 label "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 label "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 prefLabel "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 prefLabel "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 P1433 Q93368876-365B2150-7E6C-4103-98F7-46B5DA743063 @default.
- Q93368876 P1476 Q93368876-EC367A3A-5640-4BDF-8A1A-FF067A5CC695 @default.
- Q93368876 P2093 Q93368876-0B28B4AE-A133-4646-9F31-D2031263A598 @default.
- Q93368876 P2093 Q93368876-32E09D90-F280-4879-937C-E2B64CD2FA23 @default.
- Q93368876 P2093 Q93368876-67C56611-5346-45BC-AA01-3B25D97EC9C2 @default.
- Q93368876 P2093 Q93368876-9B44A3F4-7222-4C65-B741-7C93E86D0E19 @default.
- Q93368876 P2093 Q93368876-F5B26D67-AFDA-4DD5-936E-5D2EC5AC44B2 @default.
- Q93368876 P304 Q93368876-CFFA14AF-B14C-4EAA-BB4E-4E147B777393 @default.
- Q93368876 P31 Q93368876-8FE0D50E-E801-4520-AFF7-A25C4E313E93 @default.
- Q93368876 P356 Q93368876-E6897A98-9B59-4A04-A53B-A328DB569D07 @default.
- Q93368876 P433 Q93368876-EC381AC5-B5B4-461B-8D2C-2191D8B00135 @default.
- Q93368876 P478 Q93368876-979EF83A-C466-4CA3-A4B3-27D230A3E0F2 @default.
- Q93368876 P50 Q93368876-6F77DB38-7EC6-4676-A6BF-BACE79BCE058 @default.
- Q93368876 P50 Q93368876-BE23371F-D8EF-46CE-A28A-DEB83A658F2A @default.
- Q93368876 P50 Q93368876-D584A3D9-7993-47A3-85F6-B18846326715 @default.
- Q93368876 P50 Q93368876-FAA32956-263E-4A03-86B2-A6D1013E1689 @default.
- Q93368876 P577 Q93368876-2E66EFD8-699B-439E-97A9-65D1861663F9 @default.
- Q93368876 P698 Q93368876-21B87B68-3741-4832-8FC3-EA39405B92FB @default.
- Q93368876 P921 Q93368876-68905f25-4080-a6e9-cb6b-f34e455f4512 @default.
- Q93368876 P356 BJD.17454 @default.
- Q93368876 P698 30485400 @default.
- Q93368876 P1433 Q4970191 @default.
- Q93368876 P1476 "Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies" @default.
- Q93368876 P2093 "B Randazzo" @default.
- Q93368876 P2093 "M Song" @default.
- Q93368876 P2093 "S Li" @default.
- Q93368876 P2093 "Y K Shen" @default.
- Q93368876 P2093 "Y Wasfi" @default.
- Q93368876 P304 "1039-1049" @default.
- Q93368876 P31 Q13442814 @default.
- Q93368876 P356 "10.1111/BJD.17454" @default.
- Q93368876 P433 "5" @default.
- Q93368876 P478 "180" @default.
- Q93368876 P50 Q54269356 @default.
- Q93368876 P50 Q64257169 @default.
- Q93368876 P50 Q88148209 @default.
- Q93368876 P50 Q91221675 @default.
- Q93368876 P577 "2019-05-01T00:00:00Z" @default.
- Q93368876 P698 "30485400" @default.
- Q93368876 P921 Q15708315 @default.